Sunrest Lifescience
add_icon

Sunrest Lifescience

36.80
-0.10
(-0.27%)
Market Cap
31.58 Cr
PE Ratio
15.77
Volume
1,600.00
Day High - Low
36.80 - 36.80
52W High-Low
61.00 - 29.55
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
31.58 Cr
EPS
4.66
PE Ratio
15.77
PB Ratio
1.01
Book Value
36.51
EBITDA
3.00
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
12.36
Debt to Equity
0.41
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,620.40
#1 3,88,788.24
36.80
#1 54,729.00
9.71
#1 10,980
16.07
33.27
6,361.50
1,68,877.84
68.31
9,712.00
18.67
2,191
-1.02
63.24
4,117.20
1,39,344.76
61.76
11,539.40
6.99
1,911
26.24
45.65
1,317.10
1,09,930.83
20.15
33,741.20
16.73
5,725
-15.28
61.94
2,296.10
1,04,941.69
22.91
22,909.50
13.74
3,306
#1 37.44
47.90
1,295.00
1,04,607.60
23.27
28,409.50
7.12
5,291
-57.18
60.61
2,267.40
93,599.42
52.47
12,744.20
#1 20.90
2,007
7.65
67.86
927.40
93,318.14
#1 18.96
23,511.00
18.55
4,615
-0.32
55.15
1,413.80
82,113.73
23.93
32,345.60
9.43
3,484
7.59
66.95
2,299.50
64,892.08
61.93
13,435.50
6.18
1,047
15.86
63.32
Growth Rate
Revenue Growth
12.20 %
Net Income Growth
900.00 %
Cash Flow Change
109.66 %
ROE
677.36 %
ROCE
206.96 %
EBITDA Margin (Avg.)
194.16 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
11
17
27
25
30
33
19
Expenses
11
17
26
22
29
30
18
EBITDA
0
0
1
3
1
3
1
Operating Profit %
1 %
2 %
4 %
12 %
3 %
9 %
6 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
Profit Before Tax
0
0
1
3
1
3
1
Tax
0
0
0
1
0
1
-0
Net Profit
0
0
1
2
0
2
2
EPS in ₹
0.37
1.66
2.59
6.81
0.68
4.66
6.60

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
6
10
13
17
25
35
Fixed Assets
0
0
1
0
0
1
Current Assets
6
9
13
16
25
28
Capital Work in Progress
0
0
0
0
0
0
Investments
0
0
0
0
0
0
Other Assets
6
9
13
16
25
34
Total Equity & Liabilities
6
10
13
17
25
35
Current Liabilities
4
7
9
12
8
15
Non Current Liabilities
2
2
3
2
4
4
Total Equity
0
0
1
3
14
16
Reserve & Surplus
0
0
1
0
10
12
Share Capital
0
0
0
3
4
4

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
0
-0
0
Investing Activities
0
-0
-0
0
0
-1
Operating Activities
-1
0
-0
1
-15
1
Financing Activities
1
0
1
-1
15
-0

Share Holding

% Holding
Nov 2023
Mar 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
69.91 %
69.91 %
69.91 %
69.91 %
69.91 %
69.91 %
53.50 %
53.50 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
25.24 %
24.46 %
24.87 %
24.83 %
24.94 %
24.27 %
36.02 %
34.90 %
Others
4.85 %
5.63 %
5.22 %
5.26 %
5.15 %
5.82 %
10.48 %
11.60 %
No of Share Holders
742
580
505
487
459
455
498
491

Technical Indicators

RSI(14)
Neutral
46.92
ATR(14)
Less Volatile
2.09
STOCH(9,6)
Neutral
31.61
STOCH RSI(14)
Oversold
12.89
MACD(12,26)
Bearish
-0.39
ADX(14)
Weak Trend
16.93
UO(9)
Bearish
43.37
ROC(12)
Downtrend And Accelerating
-8.89
WillR(14)
Oversold
-86.35